Plain-English summaries of the compounds shown in the 5 Labs catalog. These descriptions explain research interest and biological pathways—not guaranteed outcomes or instructions for personal use.
What researchers study: Studied for its role in cellular energy regulation, metabolic signaling, glucose handling, and exercise-related physiology.
Status note: MOTS-C is an experimental research peptide and is not an FDA-approved treatment.
What researchers study: Studied in skin and tissue research for pathways related to collagen, wound repair, extracellular-matrix signaling, and hair/skin biology.
Status note: Topical copper-peptide products exist, but research claims should not be treated as proof of a medical benefit.
What researchers study: Studied as a triple receptor agonist affecting GLP-1, GIP, and glucagon pathways, with research focused on appetite, body weight, and metabolic regulation.
Status note: Retatrutide is investigational and is not FDA-approved as of this site version.
What researchers study: Acts on the growth-hormone axis and has been studied for effects on GH/IGF-1 signaling and body-fat distribution.
Status note: Tesamorelin is an FDA-approved prescription drug for a specific indication; it should not be presented as a general-purpose wellness or bodybuilding product.
What researchers study: Studied for mitochondrial membrane function, oxidative stress, cellular energy production, and age- or disease-related mitochondrial dysfunction.
Status note: Its regulatory status depends on jurisdiction and indication; research use should not be confused with approved medical treatment.
What researchers study: A three-amino-acid fragment derived from alpha-MSH that is studied in laboratory models involving inflammatory signaling, skin, and gastrointestinal biology.
Status note: Evidence is largely preclinical; it is not an FDA-approved therapy.
What researchers study: Studied for effects on growth-hormone release and GH/IGF-1 signaling. Ipamorelin is a ghrelin-receptor agonist; CJC compounds act on GHRH pathways.
Status note: These compounds are not interchangeable with approved prescription therapies and should not be marketed with unproven muscle, fat-loss, or anti-aging claims.
What researchers study: Studied historically for possible roles in sleep, stress-response signaling, pain modulation, and neuroendocrine function.
Status note: Human evidence is limited and inconsistent; it is not an FDA-approved sleep treatment.
What researchers study: A tripeptide made by the body that participates in antioxidant defense, redox balance, and detoxification pathways.
Status note: Glutathione is not typically classified as a research peptide in the same way as the other compounds on this page.
What researchers study: “Glow peptide” is not one single standardized molecule. The meaning depends on the exact ingredients in the blend, so the effects cannot be described accurately without the formula.
Status note: List the exact ingredients on the product label before making any research or mechanism description.